Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy responseYan Mei, Guangshuai Jia, Yong-Yi Feng et al.|Nature Cancer|2023Cited by 219
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47Chunliu Huang, Wenfei Jin, Xuefei Wang et al.|Nature Cancer|2024Cited by 94
Targeting tumor associated macrophages (TAMs) reprograms tumor immune microenvironment to promote solid tumor immunotherapyChunliu Huang, Jun Chen, Xiumei Wang et al.|Cellular Oncology|2024Cited by 6
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell functionYujia Liu, Yi Wei, Lixiang Wang et al.|Cellular Oncology|2024Cited by 4